Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 567.70
-5.95 (-1.04%)
Nov 4, 2025, 3:29 PM IST
Granules India Employees
Granules India had 4,066 employees as of March 31, 2025. The number of employees increased by 9 or 0.22% compared to the previous year.
Employees
4,066
Change (1Y)
9
Growth (1Y)
0.22%
Revenue / Employee
11.10M INR
Profits / Employee
1.18M INR
Market Cap
139.15B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4,066 | 9 | 0.22% |
| Mar 31, 2024 | 4,057 | 407 | 11.15% |
| Mar 31, 2023 | 3,650 | -36 | -0.98% |
| Mar 31, 2022 | 3,686 | 317 | 9.41% |
| Mar 31, 2021 | 3,369 | 340 | 11.22% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Granules India News
- 6 days ago - Granules India receives US FDA EIR with VAI classification for Bonthapally API facility - Business Upturn
- 3 months ago - Granules India Q1 Results: Revenue jumps 2.56% YoY to Rs 1,210.11 crore, net profit falls 16.37% YoY - Business Upturn
- 3 months ago - Granules India’s Hyderabad unit receives one US FDA observation after Pre-Approval Inspection - Business Upturn
- 3 months ago - Granules India CEO Kandiraju Venkata Sitaram Rao resigns, effective July 31 - Business Upturn
- 4 months ago - Granules India clears US FDA Pre-Approval Inspection with zero observations - Business Upturn
- 4 months ago - Granules India’s Bonthapally facility completes US FDA inspection with one observation - Business Upturn
- 4 months ago - Pharma scrips fall on Trump tariff threat - The Times of India
- 8 months ago - Granules India shares drop nearly 3% amid US FDA warning letter - Business Upturn